Teacher Retirement System Of Texas Theravance Biopharma, Inc. Transaction History

Teacher Retirement System Of Texas

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$8.58 - $11.4 $34,054 - $45,246	-3,969 Reduced 28.21%	10,100 $114,000
Q3 2023 Oct 31, 2023	BUY	$8.38 - $10.44 $2,899 - $3,612	346 Added 2.52%	14,069 $121,000
Q2 2023 Jul 19, 2023	SELL	$10.16 - $11.92 $18,714 - $21,956	-1,842 Reduced 11.83%	13,723 $142,000
Q1 2023 May 12, 2023	BUY	$9.87 - $11.44 $153,626 - $178,063	15,565 New	15,565 $169,000
Q2 2022 Aug 09, 2022	SELL	$8.41 - $10.34 $96,925 - $119,168	-11,525 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$8.33 - $12.96 $9,179 - $14,281	1,102 Added 10.57%	11,525 $110,000
Q4 2021 Feb 10, 2022	BUY	$7.42 - $11.05 $77,338 - $115,174	10,423 New	10,423 $115,000
Q2 2018 Aug 06, 2018	SELL	$22.06 - $25.52 $211,753 - $244,966	-9,599 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$23.37 - $29.71 $124,608 - $158,413	-5,332 Reduced 35.71%	9,599 $233,000
Q4 2017 Feb 06, 2018	BUY	$25.82 - $35.66 $385,518 - $532,439	14,931	14,931 $416,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.